Gannong Chen

发表

Subgroup Economic Evaluation of Radiotherapy for Breast Cancer After Mastectomy.

Liubao Peng, X. Wan, Yuanjian Li, 2015, Clinical therapeutics.

X-ray repair cross-complementing group 1(XRCC1) genetic polymorphisms and thyroid carcinoma risk: a meta-analysis.

Kui Liu, Zhonghua Tang, Gannong Chen, 2012, Asian Pacific journal of cancer prevention : APJCP.

Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre Analysis

E. Zhou, L. Qian, Hailong Liu, 2020, Frontiers in Oncology.

Pyrotinib Treatment in Patients With HER2-positive Metastatic Breast Cancer and Brain Metastasis: Exploratory Final Analysis of Real-World, Multicenter Data

E. Zhou, L. Qian, Hailong Liu, 2021, Clinical Cancer Research.

MicroRNA-375 targets PAX6 and inhibits the viability, migration and invasion of human breast cancer MCF-7 cells.

Qiong-yan Zou, W. Yi, Jianghai Huang, 2017, Experimental and therapeutic medicine.

miR-937-5p targets SOX17 to modulate breast cancer cell cycle and cell proliferation through the Wnt signaling pathway.

Liqin Yuan, X. Xiong, Gannong Chen, 2020, Cellular signalling.

TP73‐AS1 promotes breast cancer cell proliferation through miR‐200a‐mediated TFAM inhibition

E. Zhou, W. Yi, Feng Xu, 2018, Journal of cellular biochemistry.

Economic Outcomes of Maintenance Gefitinib for Locally Advanced/Metastatic Non-Small-Cell Lung Cancer with Unknown EGFR Mutations: A Semi-Markov Model Analysis

Qiong Lu, Chongqing Tan, Liubao Peng, 2014, PloS one.

What factors are predictive of benefit finding in women treated for non‐metastatic breast cancer? A prospective study

Yanjie Yang, Xiongzhao Zhu, L. Tang, 2015, Psycho-oncology.

Proteomic analysis reveals that MAEL, a component of nuage, interacts with stress granule proteins in cancer cells.

Baiping Wu, Jianlin Zhou, Liqin Yuan, 2014, Oncology reports.

[Psychometric features of the body image after breast cancer questionnaire-Chinese version in women with breast cancer].

Xiongzhao Zhu, L. Tang, Lingyan Li, 2014, Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences.

Cognitive emotion regulation strategies as predictors of depressive symptoms in women newly diagnosed with breast cancer

Xiongzhao Zhu, J. Yi, Lingyan Li, 2014, Psycho-oncology.

Cost-effectiveness of continuation maintenance pemetrexed after cisplatin and pemetrexed chemotherapy for advanced nonsquamous non-small-cell lung cancer: estimates from the perspective of the Chinese health care system.

Ziying Zhao, Chongqing Tan, Liubao Peng, 2013, Clinical therapeutics.

Benefit finding predicts depressive and anxious symptoms in women with breast cancer

Xiongzhao Zhu, L. Tang, J. Yi, 2015, Quality of Life Research.

Cost–Utility Analysis of the Newly Recommended Adjuvant Chemotherapy for Resectable Gastric Cancer Patients in the 2011 Chinese National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology: Gastric Cancer

W. Xiaomin, Ziying Zhao, Chongqing Tan, 2014, PharmacoEconomics.

Economic Evaluation of First-Line Adjuvant Chemotherapies for Resectable Gastric Cancer Patients in China

Ziying Zhao, Chongqing Tan, Lidan Yi, 2013, PloS one.

TP73‐AS1 promotes breast cancer cell proliferation through miR‐200a‐mediated TFAM inhibition

E. Zhou, W. Yi, Feng Xu, 2018, Journal of cellular biochemistry.

Cost-Effectiveness Analysis of Adjuvant Therapy for Operable Breast Cancer from a Chinese Perspective

J. Karnon, W. Xiaomin, Chongqing Tan, 2012, PharmacoEconomics.

Cost-effectiveness of continuation maintenance pemetrexed after cisplatin and pemetrexed chemotherapy for advanced nonsquamous non-small-cell lung cancer: estimates from the perspective of the Chinese health care system.

Ziying Zhao, Chongqing Tan, X. Wan, 2013, Clinical therapeutics.